Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Levothyroxine treatment and occurrence of fracture of the hip
Michael Sheppard
, Roger Holder, Jayne Franklyn
Birmingham Medical School
Research output
:
Contribution to journal
›
Article
54
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Levothyroxine treatment and occurrence of fracture of the hip'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Levothyroxine
100%
Medical Diagnosis
33%
Osteoporotic Fractures
33%
Femoral Fractures
33%
Fracture Risk
33%
United Kingdom
16%
Primary Care Research
16%
General Practice
16%
Confidence Interval
16%
Adjusted Odds Ratio
16%
Number of Patients
16%
Population-based
16%
Primary Care Practice
16%
Confounding
16%
Age-adjusted
16%
Thyroid Hormones
16%
Bone Mineral Density
16%
Case-control Analysis
16%
Large Cohort
16%
Major Contributor
16%
Proximal Femoral Fracture
16%
Drug Therapy
16%
Medical Therapy
16%
Levothyroxine Sodium
16%
Thyroid Hormone Replacement
16%
Medicine and Dentistry
Levothyroxine
100%
Primary Health Care
33%
Thyroid Hormone
33%
Fragility Fracture
33%
Drug Therapy
16%
General Medicine
16%
Combination Therapy
16%
Odds Ratio
16%
Bone Density
16%
Femur Fracture
16%
Levothyroxine Sodium
16%
Hormone Therapy
16%
Proximal Femur
16%
Pharmacology, Toxicology and Pharmaceutical Science
Levothyroxine
100%
Thyroid Hormone
33%
Fragility Fracture
33%
Pharmacotherapy
16%
Levothyroxine Sodium
16%
Femur Fracture
16%
Endocrine Therapy
16%